Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Plos One|June 3, 2014
Stilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cellsWolfgang Streicher, Manuel Luedeke, Anca Azoitei, et al.
The Oncologist|October 25, 2011
Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?Sandra Steffens, Viktor Grünwald, Kristina I Ringe, et al.
Urology Journal|July 13, 2014
Capsulotomy for treatment of compartment syndrome in patients with post extracorporeal shock wave lithotripsy renal hematomas: safe and effective, but also advisable?Andreas Al Ghazal, Thomas J Schnoeller, Christian Baechle, et al.
World Journal of Urology|July 6, 2012
Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancerThomas Schnoeller, Florian Jentzmik, Ludwig Rinnab, et al.
BMC Cancer|September 11, 2012
Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patientsSandra Steffens, Astrid Köhler, Raphael Rudolph, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 27, 2012
Does overweight influence the prognosis of renal cell carcinoma? Results of a multicenter studySandra Steffens, Kristina I Ringe, Katharina Schroeer, et al.
European Urology|October 30, 2010
Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?Sandra Waalkes, Frank Becker, Andres J Schrader, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 29, 2005
Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinomaSusanne Pfoertner, Ulrike Goelden, Wiebke Hansen, et al.
Plos One|June 1, 2013
Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infectionJulie Steinestel, Marcus V Cronauer, Johannes Müller, et al.
Oncotarget|July 11, 2019
Detecting predictive androgen receptor modifications in circulating prostate cancer cellsJulie Steinestel, Manuel Luedeke, Annette Arndt, et al.
Pageof 7